Literature DB >> 2047365

Promastigote infectivity in Leishmania infantum.

F Grimm1, R Brun, L Jenni.   

Abstract

Different clones and subpopulations of clones of Leishmania infantum were analyzed for their infective potential in vitro. Infectivity for macrophage-like cells (P388D1) and the response to a challenge with normal human serum enabled a clear differentiation between infective and non/low-infective populations. The results were confirmed by determination of parasite burdens in the spleens of infected golden hamsters. Long-term cultivation assays in vitro were used to test the influence of different cultivation conditions on the infectivity of promastigotes. An originally infective clone (LEM 768-A/ST) lost its infectivity during these assays but could regain it after the cultivation conditions had been changed. In addition, an originally non/low-infective clone (LEM 287-D/ST) could be forced to produce highly infective promastigotes. Infective cells were found only among stationary-phase promastigotes, i.e. after the cultures had reached a maximal number of cells per milliliter and the cell volume had clearly decreased.

Entities:  

Mesh:

Year:  1991        PMID: 2047365     DOI: 10.1007/bf00930856

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  22 in total

1.  New culture medium for maintenance of tsetse tissues and growth of trypanosomatids.

Authors:  I Cunningham
Journal:  J Protozool       Date:  1977-05

2.  Effects of promastigote growth phase, frequency of subculture, and host age on promastigote-initiated infections with Leishmania donovani in the golden hamster.

Authors:  M S Giannini
Journal:  J Protozool       Date:  1974-10

Review 3.  Developmental cycles and biology of pathogenic trypanosomes.

Authors:  K Vickerman
Journal:  Br Med Bull       Date:  1985-04       Impact factor: 4.291

4.  Growth of Leishmania donovani amastigotes in a continuous macrophage-like cell culture.

Authors:  R L Berens; J J Marr
Journal:  J Protozool       Date:  1979-08

5.  Identification of an infective stage of Leishmania promastigotes.

Authors:  D L Sacks; P V Perkins
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

6.  Development of Leishmania major in Phlebotomus duboscqi and Sergentomyia schwetzi (Diptera: Psychodidae).

Authors:  P G Lawyer; P M Ngumbi; C O Anjili; S O Odongo; Y B Mebrahtu; J I Githure; D K Koech; C R Roberts
Journal:  Am J Trop Med Hyg       Date:  1990-07       Impact factor: 2.345

7.  Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.

Authors:  E D Franke; P B McGreevy; S P Katz; D L Sacks
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Leishmania donovani metacyclic promastigotes: transformation in vitro, lectin agglutination, complement resistance, and infectivity.

Authors:  M K Howard; G Sayers; M A Miles
Journal:  Exp Parasitol       Date:  1987-10       Impact factor: 2.011

9.  Mechanism of lethal effect of human serum upon Leishmania donovani.

Authors:  R D Pearson; R T Steigbigel
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

10.  Effects of long-term in vitro cultivation on Leishmania donovani promastigotes.

Authors:  T J Nolan; R Herman
Journal:  J Protozool       Date:  1985-02
View more
  8 in total

1.  Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro.

Authors:  S W Kamau; F Grimm; A B Hehl
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.

Authors:  Maik Mettler; Felix Grimm; Gioia Capelli; Heinrich Camp; Peter Deplazes
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Polyamine content and drug sensitivities of different clonal lines of Leishmania infantum promastigotes.

Authors:  L Carrera; R Balaña-Fouce; J M Alunda
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis.

Authors:  Marliane Batista Campos; Cláudia Maria De Castro Gomes; Adelson Alcimar Almeida de Souza; Ralph Lainson; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Parasitol Res       Date:  2008-06-05       Impact factor: 2.289

5.  Impact of continuous axenic cultivation in Leishmania infantum virulence.

Authors:  Diana Moreira; Nuno Santarém; Inês Loureiro; Joana Tavares; Ana Marta Silva; Ana Marina Amorim; Ali Ouaissi; Anabela Cordeiro-da-Silva; Ricardo Silvestre
Journal:  PLoS Negl Trop Dis       Date:  2012-01-24

6.  Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantum promastigotes.

Authors:  S W Kamau; R Nunez; F Grimm
Journal:  BMC Pharmacol       Date:  2001-04-05

7.  Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.

Authors:  Marcelo P Oliveira; Vívian T Martins; Thaís T O Santos; Daniela P Lage; Fernanda F Ramos; Beatriz C S Salles; Lourena E Costa; Daniel S Dias; Patrícia A F Ribeiro; Mônica S Schneider; Ricardo A Machado-de-Ávila; Antônio L Teixeira; Eduardo A F Coelho; Miguel A Chávez-Fumagalli
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

8.  Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites.

Authors:  Rubens D M Magalhães; Mariana C Duarte; Eliciane C Mattos; Vivian T Martins; Paula S Lage; Miguel A Chávez-Fumagalli; Daniela P Lage; Daniel Menezes-Souza; Wiliam C B Régis; Maria J Manso Alves; Manuel Soto; Carlos A P Tavares; Ronaldo A P Nagen; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2014-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.